The wide range of genes, pathways and functions that are affected by MARCO in DC warrants more focused future investigation, and opens the prospect of therapeutically targeting MARCO receptor in the hope of ameliorating autoimmune disease, infections and cancer immunotherapy. This evidence concerns the gene MARCO and cancer.